LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1461

Search options

  1. Article ; Online: Relative Efficacy of Vitamin D

    Balachandar, Rakesh / Pullakhandam, Raghu / Kulkarni, Bharati / Sachdev, Harshpal Singh

    Nutrients

    2021  Volume 13, Issue 10

    Abstract: Background: Widespread prevalence of vitamin D deficiency has been documented globally. Commonly ... with either ergocalciferol (vitamin D: Methods: Randomized and non-randomized controlled studies evaluating relative ... cholecalciferol intervention was more efficacious in improving vitamin D status (serum levels of total 25(OH)D and ...

    Abstract Background: Widespread prevalence of vitamin D deficiency has been documented globally. Commonly used interventions to address this deficiency include supplementation and/or fortification with either ergocalciferol (vitamin D
    Methods: Randomized and non-randomized controlled studies evaluating relative efficacy of ergocalciferol and cholecalciferol were systematically reviewed to synthesize quantitative and qualitative evidence as per the recommendations of according to "Preferred Reporting Items for Systematic reviews and Meta-analysis" guidelines. Search terms were constructed on the basis of the "participants", "intervention", "control", "outcome" and "study type" (PICOS) strategy to systematically search the popular electronic databases. Relevant data from studies meeting inclusion and exclusion criteria were extracted and analyzed. Meta-regression, subgroup and sensitivity analyses were performed to investigate the influence of study-level characteristics including intervention dosage, frequency of dosing, interval between the last dose and test for outcome assessment, participant characteristics and analytical methods.
    Results: Apparently healthy human participants (
    Conclusions: Compared to ergocalciferol, cholecalciferol intervention was more efficacious in improving vitamin D status (serum levels of total 25(OH)D and 25(OH)D
    MeSH term(s) Cholecalciferol/blood ; Ergocalciferols/blood ; Humans ; Multivariate Analysis ; Parathyroid Hormone/blood ; Publication Bias ; Regression Analysis ; Risk
    Chemical Substances Ergocalciferols ; Parathyroid Hormone ; Cholecalciferol (1C6V77QF41)
    Language English
    Publishing date 2021-09-23
    Publishing country Switzerland
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu13103328
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Association of maternal vitamin D status with the risk of preeclampsia.

    Nema, Juhi / Wadhwani, Nisha / Randhir, Karuna / Dangat, Kamini / Pisal, Hemlata / Kadam, Vrushali / Mehendale, Savita / Wagh, Girija / Kulkarni, Bharati / Sachdev, Harshpal Singh / Fall, Caroline / Gupte, Sanjay / Joshi, Sadhana

    Food & function

    2023  Volume 14, Issue 10, Page(s) 4859–4865

    Abstract: The aim of this study was to examine serum vitamin D concentrations from early pregnancy ... vitamin D concentrations (25(OH)D) were estimated in their samples using commercially available ELISA kits ...

    Abstract The aim of this study was to examine serum vitamin D concentrations from early pregnancy until delivery in women who did and did not develop preeclampsia. This longitudinal study was carried out in Pune, India. A total of 1154 women with singleton pregnancies were recruited in early pregnancy from two hospitals. Blood samples were collected and stored at four time points across gestation: V1 = 11-14 weeks, V2 = 18-22 weeks, V3 = 26-28 weeks and V4 = at delivery. 108 women who developed preeclampsia (PE) and 216 who did not develop PE (Non-PE) were randomly selected from the remainder. Serum 25-hydroxy vitamin D concentrations (25(OH)D) were estimated in their samples using commercially available ELISA kits. Independent
    MeSH term(s) Pregnancy ; Female ; Humans ; Pre-Eclampsia/epidemiology ; Longitudinal Studies ; India/epidemiology ; Vitamin D ; Vitamins ; Vitamin D Deficiency/complications
    Chemical Substances Vitamin D (1406-16-2) ; Vitamins
    Language English
    Publishing date 2023-05-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2612033-1
    ISSN 2042-650X ; 2042-6496
    ISSN (online) 2042-650X
    ISSN 2042-6496
    DOI 10.1039/d3fo00007a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Prevalence and Correlates of Vitamin D Deficiency Among Children and Adolescents From a Nationally Representative Survey in India.

    Rana, Garima / Abraham, Ransi Ann / Sachdev, Harshpal Singh / Nair, K Madhavan / Kumar, Geeta Trilok / Agarwal, Praween Kumar / Johnston, Robert / Wagt, Arjan De / Sarna, Avina / Acharya, Rajib / Porwal, Akash / Khan, Nizamuddin / Ramesh, Sowmya / Bharti, Rahul / Kalaivani, M / Ramakrishnan, Lakshmy

    Indian pediatrics

    2023  Volume 60, Issue 3, Page(s) 202–206

    Abstract: Objective: To evaluate the prevalence of vitamin D deficiency (VDD) and its correlates ...

    Abstract Objective: To evaluate the prevalence of vitamin D deficiency (VDD) and its correlates among apparently healthy children and adolescents.
    Methods: We carried out a secondary analysis of data of Comprehensive National Nutrition Survey 2016-18 to analyze the pre-valence and predictors of VDD among Indian children and adolescents.
    Results: The over-all prevalence of VDD in preschool children (1-4 years), school age (5-9 years) children, and adolescents (10-19 years) was 13.7%, 18.2%, and 23.9%, respectively. Age, living in urban area, and winter season were significantly associated with VDD. Vegetarian diet and high-income households were the main risk factors observed in 5-19 years age category. Female sex and less than three hour of physical activity/week were independent risk factors among adolescents.
    Conclusion: The prevalence and determinants of VDD across different age-groups are reported, and these should be interpreted and addressed to decrease the burden of VDD in India.
    MeSH term(s) Child, Preschool ; Humans ; Female ; Adolescent ; Child ; Vitamin D ; Prevalence ; Vitamin D Deficiency/epidemiology ; Nutritional Status ; India/epidemiology
    Chemical Substances Vitamin D (1406-16-2)
    Language English
    Publishing date 2023-01-02
    Publishing country India
    Document type Journal Article
    ZDB-ID 402594-5
    ISSN 0974-7559 ; 0019-6061
    ISSN (online) 0974-7559
    ISSN 0019-6061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Indian Academy of Pediatrics Revised (2021) Guidelines on Prevention and Treatment of Vitamin D Deficiency and Rickets.

    Gupta, Piyush / Dabas, Aashima / Seth, Anju / Bhatia, Vijay Lakshmi / Khadgawat, Rajesh / Kumar, Praveen / Balasubramanian, S / Khadilkar, Vaman / Mallikarjuna, H B / Godbole, Tushar / Krishnamurthy, Sriram / Goyal, Jagdish Prasad / Bhakhri, Bhanu Kiran / Ahmad, Ayesha / Angadi, Kumar / Basavaraj, G V / Parekh, Bakul J / Kurpad, Anura / Marwaha, R K /
    Shah, Dheeraj / Munns, Craig / Sachdev, H P S

    Indian pediatrics

    2021  Volume 59, Issue 2, Page(s) 142–158

    Abstract: Justification: The emerging literature on prevalence of vitamin D deficiency in India, prevention ... and treatment strategies of rickets, and extra-skeletal benefits of vitamin D suggest the need ... for revising the existing guidelines for prevention and treatment of vitamin D deficiency in India ...

    Abstract Justification: The emerging literature on prevalence of vitamin D deficiency in India, prevention and treatment strategies of rickets, and extra-skeletal benefits of vitamin D suggest the need for revising the existing guidelines for prevention and treatment of vitamin D deficiency in India.
    Objectives: To review the emerging literature on vitamin D prevalence and need for universal vitamin D supplementation. To suggest optimum vitamin D therapy for treatment of asymptomatic and symptomatic vitamin D deficiency, and rickets. To evaluate the extra-skeletal health benefits of vitamin D in children.
    Process: A National consultative committee was formed that comprised of clinicians, epidemiologists, endocrinologists, and nutritionists. The Committee conducted deliberations on different aspects of vitamin D deficiency and rickets through ten online meetings between March and September, 2021. A draft guideline was formulated, which was reviewed and approved by all Committee members.
    Recommendations: The group reiterates the serum 25-hydroxy vitamin D cutoffs proposed for vitamin D deficiency, insufficiency, and sufficiency as <12 ng/mL, 12-20 ng/mL and >20 ng/mL, respectively. Vitamin D toxicity is defined as serum 25OHD >100 ng/mL with hypercalcemia and/or hypercalciuria. Vitamin D supplementation in doses of 400 IU/day is recommended during infancy; however, the estimated average requirement in older children and adolescents (400-600 IU/day, respectively) should be met from diet and natural sources like sunlight. Rickets and vitamin D deficiency should be treated with oral cholecalciferol, preferably in a daily dosing schedule (2000 IU below 1 year of age and 3000 IU in older children) for 12 weeks. If compliance to daily dosing cannot be ensured, intermittent regimens may be prescribed for children above 6 months of age. Universal vitamin D supplementation is not recommended in childhood pneumonia, diarrhea, tuberculosis, HIV and non-infectious conditions like asthma, atopic dermatitis, and developmental disorders. Serum 25-hydroxy vitamin D level of >20 ng/mL should be maintained in children with conditions at high-risk for vitamin deficiency, like nephrotic syndrome, chronic liver disease, chronic renal failure, and intake of anticonvulsants or glucocorticoids.
    MeSH term(s) Adolescent ; Child ; Cholecalciferol/therapeutic use ; Dietary Supplements ; Humans ; Pediatrics ; Rickets/drug therapy ; Rickets/prevention & control ; Vitamin D ; Vitamin D Deficiency/drug therapy ; Vitamin D Deficiency/epidemiology ; Vitamin D Deficiency/prevention & control ; Vitamins/therapeutic use
    Chemical Substances Vitamins ; Vitamin D (1406-16-2) ; Cholecalciferol (1C6V77QF41)
    Language English
    Publishing date 2021-12-29
    Publishing country India
    Document type Journal Article
    ZDB-ID 402594-5
    ISSN 0974-7559 ; 0019-6061
    ISSN (online) 0974-7559
    ISSN 0019-6061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth.

    Marinec, Paul S / Landgraf, Kyle E / Uppalapati, Maruti / Chen, Gang / Xie, Daniel / Jiang, Qiyang / Zhao, Yanlong / Petriello, Annalise / Deshayes, Kurt / Kent, Stephen B H / Ault-Riche, Dana / Sidhu, Sachdev S

    ACS chemical biology

    2021  Volume 16, Issue 3, Page(s) 548–556

    Abstract: We report a general approach to engineering multivalent d-proteins with antibody-like activities ...

    Abstract We report a general approach to engineering multivalent d-proteins with antibody-like activities
    MeSH term(s) Amino Acid Sequence ; Animals ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Bevacizumab/pharmacology ; Binding Sites ; Drug Evaluation, Preclinical ; Eye/drug effects ; Female ; Humans ; Mice ; Models, Molecular ; Neoplasms/drug therapy ; Peptide Library ; Peptides/chemistry ; Peptides/pharmacology ; Protein Binding ; Protein Conformation ; Protein Multimerization ; Rabbits ; Receptors, Vascular Endothelial Growth Factor/chemistry ; Receptors, Vascular Endothelial Growth Factor/metabolism ; Retinal Vessels/drug effects ; Vascular Endothelial Growth Factor A/antagonists & inhibitors
    Chemical Substances Antineoplastic Agents ; Peptide Library ; Peptides ; Vascular Endothelial Growth Factor A ; Bevacizumab (2S9ZZM9Q9V) ; Receptors, Vascular Endothelial Growth Factor (EC 2.7.10.1)
    Language English
    Publishing date 2021-02-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1554-8937
    ISSN (online) 1554-8937
    DOI 10.1021/acschembio.1c00017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Retraction Note to: Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons.

    Braidy, Nady / Brew, Bruce J / Inestrosa, Nibaldo C / Chung, Roger / Sachdev, Perminder / Guillemin, Gilles J

    Metabolic brain disease

    2023  Volume 38, Issue 6, Page(s) 2197

    Language English
    Publishing date 2023-06-05
    Publishing country United States
    Document type Retraction of Publication
    ZDB-ID 632824-6
    ISSN 1573-7365 ; 0885-7490
    ISSN (online) 1573-7365
    ISSN 0885-7490
    DOI 10.1007/s11011-023-01241-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Vitamin D Sufficiency through Sunshine in Infants?

    Goswami, R / S Sachdev, H P

    Indian pediatrics

    2017  Volume 54, Issue 2, Page(s) 103–104

    MeSH term(s) Humans ; Infant ; Sunlight ; Vitamin D ; Vitamin D Deficiency ; Vitamins
    Chemical Substances Vitamins ; Vitamin D (1406-16-2)
    Language English
    Publishing date 2017-02-21
    Publishing country India
    Document type Journal Article ; Comment
    ZDB-ID 402594-5
    ISSN 0974-7559 ; 0019-6061
    ISSN (online) 0974-7559
    ISSN 0019-6061
    DOI 10.1007/s13312-017-1009-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: D-(+)-Pinitol, an oviposition stimulant for the pipevine swallowtail butterfly,Battus philenor.

    Papaj, D R / Feeny, P / Sachdev-Gupta, K / Rosenberry, L

    Journal of chemical ecology

    2013  Volume 18, Issue 5, Page(s) 799–815

    Abstract: ... by contact with alcoholic extracts of host foliage.D-(+)-Pinitol was isolated and identified from leaf ...

    Abstract Oviposition by females of the pipevine swallowtail butterfly,Battus philenor, was stimulated by contact with alcoholic extracts of host foliage.D-(+)-Pinitol was isolated and identified from leaf material of one host species,Aristolochia macrophylla (Aristolochiaceae). In combination with chloroform-soluble components of host leaf material, this compound was comparable to the parent extract in stimulating oviposition.
    Language English
    Publishing date 2013-11-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 800130-3
    ISSN 1573-1561 ; 0098-0331
    ISSN (online) 1573-1561
    ISSN 0098-0331
    DOI 10.1007/BF00994616
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Relative Efficacy of Vitamin D2 and Vitamin D3 in Improving Vitamin D Status: Systematic Review and Meta-Analysis

    Balachandar, Rakesh / Pullakhandam, Raghu / Kulkarni, Bharati / Sachdev, Harshpal Singh

    Nutrients. 2021 Sept. 23, v. 13, no. 10

    2021  

    Abstract: Background: Widespread prevalence of vitamin D deficiency has been documented globally. Commonly ... cholecalciferol (vitamin D₃) for raising the serum levels of vitamin D metabolites and functional indicators ... The quantitative analysis suggested higher efficacy of cholecalciferol than ergocalciferol in improving total 25(OH)D (mean ...

    Abstract Background: Widespread prevalence of vitamin D deficiency has been documented globally. Commonly used interventions to address this deficiency include supplementation and/or fortification with either ergocalciferol (vitamin D₂) or cholecalciferol (vitamin D₃), but the relative efficacy of these two vitamers is unclear. The current study aimed to evaluate the relative efficacy of ergocalciferol (vitamin D₂) and cholecalciferol (vitamin D₃) for raising the serum levels of vitamin D metabolites and functional indicators including serum parathyroid (PTH) levels, isometric muscle strength, hand grip strength and bone mineral density. Methods: Randomized and non-randomized controlled studies evaluating relative efficacy of ergocalciferol and cholecalciferol were systematically reviewed to synthesize quantitative and qualitative evidence as per the recommendations of according to “Preferred Reporting Items for Systematic reviews and Meta-analysis” guidelines. Search terms were constructed on the basis of the “participants”, “intervention”, “control”, “outcome” and “study type” (PICOS) strategy to systematically search the popular electronic databases. Relevant data from studies meeting inclusion and exclusion criteria were extracted and analyzed. Meta-regression, subgroup and sensitivity analyses were performed to investigate the influence of study-level characteristics including intervention dosage, frequency of dosing, interval between the last dose and test for outcome assessment, participant characteristics and analytical methods. Results: Apparently healthy human participants (n = 1277) from 24 studies were included for meta-analysis. The quantitative analysis suggested higher efficacy of cholecalciferol than ergocalciferol in improving total 25(OH)D (mean difference: 15.69, 95%CI: 9.46 to 21.93 nmol/L) and reducing PTH levels, consistently across variable participant demographics, dosage and vehicle of supplementation. Meta-regression suggested smaller differences in the efficacy of cholecalciferol and ergocalciferol at lower doses. Average daily dose was the single significant predictor of effect size, as revealed by multivariate meta-regression analysis. Conclusions: Compared to ergocalciferol, cholecalciferol intervention was more efficacious in improving vitamin D status (serum levels of total 25(OH)D and 25(OH)D₃) and regulating PTH levels, irrespective of the participant demographics, dosage and vehicle of supplementation.
    Keywords average daily intake ; blood serum ; bone density ; cholecalciferol ; demographic statistics ; ergocalciferol ; hand strength ; humans ; meta-analysis ; metabolites ; quantitative analysis ; regression analysis ; systematic review
    Language English
    Dates of publication 2021-0923
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2518386-2
    ISSN 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu13103328
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: A Potent d-Protein Antagonist of VEGF-A is Nonimmunogenic, Metabolically Stable, and Longer-Circulating in Vivo.

    Uppalapati, Maruti / Lee, Dong Jun / Mandal, Kalyaneswar / Li, Hongyan / Miranda, Les P / Lowitz, Joshua / Kenney, John / Adams, Jarrett J / Ault-Riché, Dana / Kent, Stephen B H / Sidhu, Sachdev S

    ACS chemical biology

    2016  Volume 11, Issue 4, Page(s) 1058–1065

    Abstract: Polypeptides composed entirely of d-amino acids and the achiral amino acid glycine (d-proteins ... agent. Specifically, d-proteins are resistant to degradation by proteases and are anticipated to be ... nonimmunogenic. Furthermore, d-proteins are manufactured chemically and can be engineered to have other desirable ...

    Abstract Polypeptides composed entirely of d-amino acids and the achiral amino acid glycine (d-proteins) inherently have in vivo properties that are proposed to be near-optimal for a large molecule therapeutic agent. Specifically, d-proteins are resistant to degradation by proteases and are anticipated to be nonimmunogenic. Furthermore, d-proteins are manufactured chemically and can be engineered to have other desirable properties, such as improved stability, affinity, and pharmacokinetics. Thus, a well-designed d-protein therapeutic would likely have significant advantages over l-protein drugs. Toward the goal of developing d-protein therapeutics, we previously generated RFX001.D, a d-protein antagonist of natural vascular endothelial growth factor A (VEGF-A) that inhibited binding to its receptor. However, RFX001.D is unstable at physiological temperatures (Tm = 33 °C). Here, we describe RFX037.D, a variant of RFX001.D with extreme thermal stability (Tm > 95 °C), high affinity for VEGF-A (Kd = 6 nM), and improved receptor blocking. Comparison of the two enantiomeric forms of RFX037 revealed that the d-protein is more stable in mouse, monkey, and human plasma and has a longer half-life in vivo in mice. Significantly, RFX037.D was nonimmunogenic in mice, whereas the l-enantiomer generated a strong immune response. These results confirm the potential utility of synthetic d-proteins as alternatives to therapeutic antibodies.
    MeSH term(s) Calibration ; Circular Dichroism ; Humans ; Mass Spectrometry ; Reference Standards ; Surface Plasmon Resonance ; Vascular Endothelial Growth Factor A/antagonists & inhibitors
    Chemical Substances Vascular Endothelial Growth Factor A
    Language English
    Publishing date 2016-04-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ISSN 1554-8937
    ISSN (online) 1554-8937
    DOI 10.1021/acschembio.5b01006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top